-+ 0.00%
-+ 0.00%
-+ 0.00%

Molina Healthcare (MOH) On Weak Earnings And Flat Guidance Looks Modestly Undervalued

Simply Wall St·11/03/2026 15:27:01
语音播报

Why Molina Healthcare stock is in focus now

Molina Healthcare (MOH) is back under the microscope after weaker third quarter figures, softer year to date earnings and fresh guidance that points to flat premium revenue in 2026.

The recent sell off around the third quarter miss and flat 2026 premium guidance has come after a strong run, with Molina Healthcare showing a 30 day share price return of 9.98% and a year to date share price gain of 16.80% off a US$208.45 level. At the same time, the 1 year total shareholder return of 41.77% contrasts with a weaker 3 year and 5 year total shareholder return where investors have seen declines. This suggests momentum has picked up in the short term even as the longer record still reflects earlier setbacks and changing expectations around risk.

See how Molina Healthcare compares with other managed care and defensive operators by reviewing our curated list of 29 resilient stocks with low risk scores.

Bulls view Molina Healthcare as a reset story after a sharp earnings hit, while bears see a value trap tied to flat premium guidance. Which side do the current valuation markers favor?

Most Popular Narrative: 4% Undervalued

The most followed valuation narrative pegs Molina Healthcare’s fair value at $216.29 against a last close of $208.45. This means the current setup leans modestly in favor of the bulls while still demanding clean execution on the plan.

Already won Medicaid contracts and embedded revenue, including large programs in Florida, Georgia, Texas and Illinois, together with management’s plan to reach $64b of premium by 2029 from $42b in 2026, describe a pipeline of growth that can feed revenue and earnings without relying solely on new wins.

See why 64 investors see Molina Healthcare as 4% undervalued.

Result: Fair Value of $216.29 (UNDERVALUED)

Still, the bullish Molina Healthcare story can unravel quickly if Medicaid funding or rate decisions fall short of expectations and ACA Marketplace losses persist longer than analysts model.

Find out about the key risks to this Molina Healthcare narrative.

Next Steps

If this Molina Healthcare story feels finely balanced, treat that as a prompt to check the data yourself and act promptly based on your own judgment. To see what the optimism is built on, review the 3 key rewards.

Looking for more investment ideas beyond Molina Healthcare?

Do not stop with Molina Healthcare. Use this momentum to upgrade your watchlist with fresh ideas that match your risk profile and income goals.